Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FHPDC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,895
Award facts
- Contract value 100% obligated
- $11,894.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, issued on March 5, 2025, awards AmerisourceBergen Drug Corp a firm fixed-price contract valued at $11,894.55 for the supply of ENBREL 50 mg/mL SureClick auto-injectors. The Defense Logistics Agency (DLA), a defense agency, issued this non-competitive delivery order under its existing Indefinite Delivery Contract (IDC) with AmerisourceBergen, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with a completion date of March 6, 2025, reflecting the expedited nature of this pharmaceutical supply requirement.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health Agency and military healthcare systems. As a prime contractor under the DLA Troop Support Medical's comprehensive global pharmaceutical support vehicle, the company supplies a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. This delivery order for ENBREL, a biologic treatment for autoimmune conditions, exemplifies the company's role in supporting military and veteran healthcare through the DLA Medical Supply Chain. The award was made without set-aside designation, consistent with AmerisourceBergen's competitive positioning in federal pharmaceutical procurement.
Quick answers
Who was awarded contract SPE2DB25FHPDC?
SPE2DB25FHPDC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 5, 2025.
How much is contract SPE2DB25FHPDC worth?
The government has obligated $11,895 on SPE2DB25FHPDC.
Is contract SPE2DB25FHPDC an order under another contract?
Yes. SPE2DB25FHPDC is a delivery order under SPE2DB24D2212, an indefinite delivery contract.
Was contract SPE2DB25FHPDC competed?
The extent of competition for SPE2DB25FHPDC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award